Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival

BACKGROUND: Patients with peritoneal metastases (PMs) originating from colorectal carcinoma (CRC) are curatively treated by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C (MMC). We aim to improve patient selection for HIPEC by predicting MMC sensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwakman, R, de Cuba, E M V, de Winter, J P, de Hingh, I H J T, Delis-van Diemen, P M, Tijssen, M, Rooimans, M A, Krijgsman, O, Carvalho, B, Peters, G J, Bonjer, H J, Meijer, G A, te Velde, E A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453952/
https://www.ncbi.nlm.nih.gov/pubmed/25668003
http://dx.doi.org/10.1038/bjc.2015.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453952/
https://www.ncbi.nlm.nih.gov/pubmed/25668003
http://dx.doi.org/10.1038/bjc.2015.18

Ejemplares similares